MS Pharma is a multinational pharmaceutical company headquartered in Amman – Jordan that manufactures and markets innovative products across Middle East, Africa and Europe. The company leverages 9 manufacturing sites in Algeria, Jordan, Turkey, KSA and Greece to sell its products in over 60 countries worldwide, with a capacity of 600 million boxes per year.

United Pharmaceuticals was founded in 1989 in Jordan, and since then it has been working on developing, manufacturing and marketing a wide range of high-quality brands in the local market and exporting them to more than 20 countries worldwide. United pharmaceuticals was the 1^st in the region to achieve the European Good Manufacturing Practice (European-GMP) Certificate.

El KENDI is one of the top leading pharmaceutical companies in Algeria, where it is now the number one as a local manufacturing generic company there.

El KENDI’s factory was the 1^st to get the FDA Certificate in the region, with more than 1200 highly skilled and well experienced employees, most of them are of the youth generation who are full of innovative and creative ideas along with enthusiasm.

MS Pharma Injectables is one of a kind, where the factory can manufacture all injectable dosage forms and hospital infusion bags, where the factory was built according to the highest and latest international standards, which go along with the rules and regulations set by the World Health Organization – Good Manufacturing Practice (WHO-GMP).

MS Pharma Turkey has been established in September 2016, where it includes a factory for injectable forms with a total area of 18,000 m2 (meter square).

The factory was added to the group matching with MS Pharma’s vision to penetrate the Turkish market strongly as well as other European markets.

MS Pharma Saudi was established in 2018, as a setup with 3 different manufacturing facilities specialized in oral and injectable drugs for multipurpose use and oncology medications as well.

The Greek company Genepharm has been acquired by MS Pharma during the 1^st semester of 2019, where Genepharm, that is based in Athens and founded in 1967, works on the development, manufacturing, marketing and out-licensing of high-value generic pharmaceutical products in different countries.